The fatty acid composition of the serum phospholipids of children with sickle cell disease in Nigeria

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 67, Issue 4, 2002, Pages 217-222

  Glew, R H ^a   Casados, J K ^a   Huang, Y S ^b   Chuang, L T ^b   VanderJagt, D J ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; FATTY ACID; LINOLEIC ACID; MEMBRANE PHOSPHOLIPID; PHOSPHOLIPID; STEARIC ACID; DOCOSAHEXAENOIC ACID; EICOSAPENTANOIC ACID; UNSATURATED FATTY ACID;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HORMONE RECEPTOR INTERACTION; HUMAN; ION TRANSPORT; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; MEMBRANE FLUIDITY; NIGERIA; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SIGNAL TRANSDUCTION; BLOOD; CASE CONTROL STUDY; CHEMISTRY; PRESCHOOL CHILD; SEX DIFFERENCE; TEMPERATURE;

ADOLESCENT; ANEMIA, SICKLE CELL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; NIGERIA; PHOSPHOLIPIDS; SEX FACTORS; TEMPERATURE;

EID: 0036799093     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2002.0423     Document Type: Article

References (19)

1. Platt O. S., Brambilla D. J., Ross W. F. Mortality in sickle cell disease: Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-1664.
2. Konotey-Ahulu F. I. D. History of sickle cell disease in Africa. Geographical distribution and population dynamics of haemoglobin S and C with special reference to West Africa. Ghana Med J 1972; 11: 397.
3. Phebus C. K., Gloninger M. F., Maciak B.J. Growth patterns by age and sex in children with sickle cell disease. J Pediatr 1984; 105: 28-33.
4. Singhal A., Thomas P., Cook R., Wierenga K., Serjeant G. Delayed adolescent growth in homozygous sickle cell disease. Arch Dis Child 1994; 71: 404-408.
5. Henderson R. A., Saavedra J. M., Dover G. J. Prevalence of impaired growth in children with homozygous sickle cell anemia. Am J Med Sci 1994; 307: 405-407.
6. Luban B. L., Leiken S. L., August G. A. Growth and development in sickle cell anemia. Am J Pediatr Hematol Oncol 1982; 4: 61-65.
7. Olambiwonnu N. O., Penny R., Frasier S. D. Sexual maturation in subjects with sickle cell anemia: Studies of serum gonadotropin concentration, height, weight, and skeletal age. Adol Med 1975; 87: 459-464.
8. Abbasi A. A., Prasad A. S., Ortega J., Congco E., Oberleas D. Gonadal function abnormalities in sickle cell anemia. Ann Int Med 1976; 85: 601-605.
9. Lande W. M., Andrews D. L., Clark M. R., et al. The incidence of painful crisis in homozygous sickle cell disease: Correlation with red cell deformability. Blood 1988; 72: 2056-2059.
10. Hebbel R. P., Ney P. A., Foker W. Autoxidation, dehydration, and adhesivity may be related abnormalities of sickle erythrocytes. Am J Physiol 1989; 256: C579-C583.
11. Enomoto T. M., Isichei C., VanderJagt D. J., et al. Decreased polyunsaturated fatty acids in sickle cell anaemia. J Trop Pediatr 1998; 44: 28-34.
12. Holman R. T. Essential fatty acid deficiency. Prog Chem Fats Other Lipids 1968; 9: 275-348.
13. Conner W. E., Lin D. S., Thomas G., Ey F., DeLoughery T., Zhu N. Abnormal phospholipid molecular species of erythrocytes in sickle cell anemia. J Lipid Res 1997; 38: 2516-2528.
14. Jensen R. G., Patton S. The effect of matemal diets on the mean melting points of human milk fatty acid. Lipids 2000; 35: 1159-1161.
15. Morrison W. R., Smith L. M. Preparation of fatty acid methyl esters and dimethyl acetals from lipids boron fluoride-methanol. J Lipid Res 1964; 5: 600-608.
16. Muskiet F. D., Muskiet F. A. Lipids, fatty acids and trace elements in plasma and erythrocytes of pediatric patients with homozygous sickle cell disease. Clin Chim Acta 1984; 142: 1-10.
17. Holman R. T., Johnson S. B., Kokmen E. Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proc Natl Acad Sci USA 1989; 86: 4720-4724.
18. Tomer A., Kasey S., Connor W. E., Clark S., Harker L. A., Eckman J. R. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost 2001; 85: 966-974.
19. Muskiet F. A., Muskiet F. D., Meiborg G., Schermer J. G. Supplementation of patients with homozygous sickle cell disease with zinc, α-tocopherol, vitamin C, soybean oil, and fish oil. Am J Clin Nutr 1991; 54: 736-744.